Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc

3002 (Harmonized System 1992 for 4-digit)

About

Overview This page contains the latest trade data of Vaccines, blood, antisera, toxins and cultures. In 2021, Vaccines, blood, antisera, toxins and cultures were the world's 11th most traded product, with a total trade of $332B. Between 2020 and 2021 the exports of Vaccines, blood, antisera, toxins and cultures grew by 51.9%, from $219B to $332B. Trade in Vaccines, blood, antisera, toxins and cultures represent 1.58% of total world trade.

Vaccines, blood, antisera, toxins and cultures are a part of Pharmaceutical products. They include Antisera and other blood fractions, Vaccines, human use, Blood, toxins, cultures, medical use, nes, Vaccines, veterinary use, except foot and mouth, and Vaccines, foot and mouth disease, veterinary use.

Exports In 2021 the top exporters of Vaccines, blood, antisera, toxins and cultures  were Belgium ($47.2B), Germany ($45.6B), United States ($45.3B), Switzerland ($40.3B), and Ireland ($36.5B).

Imports In 2021 the top importers of Vaccines, blood, antisera, toxins and cultures were United States ($52.7B), Germany ($41.6B), Belgium ($22.5B), Japan ($14.7B), and France ($13B).

Ranking Vaccines, blood, antisera, toxins and cultures ranks 81st in the Product Complexity Index (PCI).

Description Human blood is used to provide oxygen and nutrients to the tissues and to carry away waste products from the tissues. Animal blood prepared for therapeutic, prophylactic or diagnostic uses is used to study blood-borne diseases and to provide antibodies that are used in the diagnosis of diseases. Antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes, are used in the diagnosis of diseases. Vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar products are used in the prevention and treatment of diseases.

Latest Data

View
Flow
Y-AXIS SCALE

The following visualization shows the latest trends on Vaccines, blood, antisera, toxins and cultures. Countries are shown based on data availability.

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

* Using January 2020 exchange rates when trade data is reported in local currency.

Explore Latest Trends

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Exporters and Importers

Top Origin (2021)Belgium$47.2B
Top Destination (2021)United States$52.7B

In 2021 Vaccines, blood, antisera, toxins and cultures were the world's 11th most traded product (out of 1,217).

In 2021, the top exporters of Vaccines, blood, antisera, toxins and cultures were Belgium ($47.2B), Germany ($45.6B), United States ($45.3B), Switzerland ($40.3B), and Ireland ($36.5B).

In 2021, the top importers of Vaccines, blood, antisera, toxins and cultures were United States ($52.7B), Germany ($41.6B), Belgium ($22.5B), Japan ($14.7B), and France ($13B).

Explore Visualizations

Exporters of Vaccines, blood, antisera, toxins and cultures (2021)
[Click to Select a Country]

Importers of Vaccines, blood, antisera, toxins and cultures (2021)
[Click to Select a Country]

Market Dynamics

Color
Top Origin Growth (2020 -  2021)Belgium$25.9B
Top Destination Growth (2020 -  2021)Germany$16B

Between 2020 and 2021, the exports of Vaccines, blood, antisera, toxins and cultures grew the fastest in Belgium ($25.9B), China ($21.8B), United States ($15.6B), Germany ($11.5B), and Switzerland ($9.92B).

Between 2020 and 2021, the fastest growing importers of Vaccines, blood, antisera, toxins and cultures were Germany ($16B), United States ($8.1B), Japan ($6.77B), Spain ($6.72B), and Belgium ($6.18B).

Explore Visualizations

Exporters of Vaccines, blood, antisera, toxins and cultures (2020 - 2021)

Importers of Vaccines, blood, antisera, toxins and cultures (2020 - 2021)

Market Concentration

Value

This chart shows the evolution of the market concentration of exports of Vaccines, blood, antisera, toxins and cultures.

In 2021, market concentration measured using Shannon Entropy, was 3.84. This means that most of the exports of Vaccines, blood, antisera, toxins and cultures are explained by 14 countries.

Explore Visualizations

Value of Exports in Vaccines, blood, antisera, toxins and cultures

Net Trade

TOP NET EXPORTER (2021)Ireland$31.5B
TOP NET IMPORTER (2021)Japan$11B

This map shows which countries export or import more of Vaccines, blood, antisera, toxins and cultures. Each country is colored based on the difference in exports and imports of Vaccines, blood, antisera, toxins and cultures during 2021.

In 2021, the countries that had a largest trade value in exports than in imports of Vaccines, blood, antisera, toxins and cultures were Ireland ($31.5B), Switzerland ($29.1B), Belgium ($24.7B), China ($13B), and Netherlands ($4.38B).

In 2021, the countries that had a largest trade value in imports than in exports of Vaccines, blood, antisera, toxins and cultures were Japan ($11B), United States ($7.4B), Canada ($7.38B), United Kingdom ($6.49B), and Brazil ($6.25B).

Net Trade (2021)

Disaggregation

Value

In 2021, the world most traded Vaccines, blood, antisera, toxins and cultures, disaggragated by their HS6 level were Antisera and other blood fractions ($200B), Vaccines, human use ($115B), Blood, toxins, cultures, medical use, nes ($12.4B), and Vaccines, veterinary use, except foot and... ($4.32B)

HS6 Disaggregation for Vaccines, blood, antisera, toxins and cultures (2021)
[Click to Select]

Country Comparison

Flow
Measure
Ranking

This visualization shows the countries that have an important ratio of their trade related to Vaccines, blood, antisera, toxins and cultures.
It is possible to select the main countries that export or import Vaccines, blood, antisera, toxins and cultures in the world, or by continent, as well as select the measure of interest.

Top 10 Exporters Countries of Vaccines, blood, antisera, toxins and cultures by percentage of total exports

Product Complexity

Diversification Frontier

Specialization

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.

Relatedness vs Country Complexity (2021)

Country by Relatedness

The following visualization shows the relatedness of Vaccines, blood, antisera, toxins and cultures to countries. Higher relatedness values ​​indicate greater knowledge, which predicts a greater probability of exporting that product in the future.

Relative Relatedness by Country (2021)

Have questions, comments, or concerns?
Send us an e-mail: [email protected]
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with